Showing results (41-50 of 138) with videos related to
Sort By:
Pageof 14
Contraception|October 1, 1994
The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acneT O Dieben, L Vromans, A Theeuwes, et al.Molecular Endocrinology (Baltimore, Md.)|January 11, 2000
Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaBF Lezoualc'h, S Engert, B Berning, et al.Fertility and Sterility|May 1, 1983
The effect of pulsatile and continuous intravenous luteinizing hormone-releasing hormone administration on pituitary luteinizing hormone and follicle-stimulating hormone release in normal menB C Fauser, J M Dony, W H Doesburg, et al.Neuroscience Letters|November 25, 2000
Dexamethasone-enhanced sensitivity of mouse hippocampal HT22 cells for oxidative stress is associated with the suppression of nuclear factor-kappaBS Braun, W Liebetrau, B Berning, et al.Journal of Steroid Biochemistry|October 1, 1989
Granulosa cell aromatase bioassay: changes of bioactive FSH levels in the femaleB C Fauser, D Soto, N M Czekala, et al.Fertility and Sterility|January 13, 2000
Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of cultureG J Huisman, B C Fauser, M J Eijkemans, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 26, 1998
A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in ThailandO Kiriwat, A Patanayindee, S Koetsawang, et al.Nederlands Tijdschrift Voor Geneeskunde|February 1, 2008
[Virilisation due to an ovarian mucinous cystadenoma]H Scheper, J van Dillen, P Blok, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndromeI Schipper, F F Rommerts, P M Ten Hacken, et al.Radiology|May 1, 1992
How to discriminate between normal and polycystic ovaries: transvaginal US studyT D Pache, J W Wladimiroff, W C Hop, et al.Pageof 14